Cameron C. Trenor III
CIK: 0002150478
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANTX
AN2 Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Trenor Cameron C. III
Trenor Cameron C. III (SEC CIK 0002150478) files insider reports with the SEC as Chief Medical Officer of AN2 Therapeutics, Inc. (ANTX).
Signal8 holds 2 ownership filings by Trenor Cameron C. III (1 Form 3, 1 Form 4), filed between Aug 27, 2026 and Sep 16, 2026. Those filings report 1 transaction, the latest on Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Trenor Cameron C. III's filings is in MENLO PARK, CA.
Recent filings by Trenor Cameron C. III
- Sep 15, 2026: Grant or award of ANTX shares (Form 4, code A).
Other insiders filing for AN2 Therapeutics, Inc. (ANTX)
- Marks Gilbert Lynn, Director
- Martin Patricia A., Director
- Aziz Kabeer, Director
- Readnour Robin Shane, Director
- Williams Sarah Joanne, Principal Accounting Officer
- FitzPatrick Margaret M, Director